Global Genome Engineering
Global Genome Engineering

Genome Engineering Comprehensive Study by Type (Reagents & Consumables, Software & Systems, Services), Application (Cell Line Engineering , Animal Genetic Engineering , Plant Genetic Engineering , Others), Technology (CRISPR, TALEN, ZFN, Antisense, Other Technologies), End User (Biotechnology & Pharmaceutical Companies, Research Institutes, Contract Research Organizations) Players and Region - Global Market Outlook to 2026

Genome Engineering Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Feb 2021 Edition 245 Pages 196 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Genome Engineering Market?

Genome Engineering enables scientists to make changes to DNA, leading to changes in physical traits, like eye color, and disease risk. These technologies act like scissors, cutting the DNA at a specific spot. Then scientists can remove, add, or replace the DNA where it was cut. Scientists are developing gene therapies - treatments involving genome engineering - to prevent and treat diseases in humans. Genome engineering tools have the potential to help treat diseases with a genomic basis, like cystic fibrosis and diabetes, etc.

The market study is being classified by Type (Reagents & Consumables, Software & Systems and Services), by Application (Cell Line Engineering , Animal Genetic Engineering , Plant Genetic Engineering  and Others) and major geographies with country level break-up.

Thermo Fisher Scientific (United States), Merck & Co (Germany), Horizon Discovery Limited (United Kingdom), Genscript USA (United States), Sangamo Therapeutics (United States), Integrated DNA Technologies (United States), Lonza Group (Switzerland), New England Biolabs (United States), Origene Technologies (United States) and Transposagen Biopharmaceuticals (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Cellecta (United States), Genecopoeia (United States) and Calyxt (United States).

The companies operating in this sector are concentrating more on efficient growth, upgrading operational efficiency and productivity, realizing high safety standards, and focus on maintaining sustainable development. The players are focusing on securing the leading position in this industry. They are uninterruptedly observing for the prospect to reinforce their economic advantage. To meet a high market share, and developing socially responsible business companies are identifying various strategic initiatives such as mergers & acquisitions, new product launch, product enhancement, and others. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Genome Engineering market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Genome Engineering market by Type, Application and Region.

On the basis of geography, the market of Genome Engineering has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increasing Development of Novel Technologies in Genome Engineering
  • Surging Prevalence of Genetic Disorders

Market Trend
  • Rising Governments Fundings for R&D in Genome Engineering
  • Increasing Number of Strategic Initiative by Leading Players across the Industry

Restraints
  • High Cost of Genome Engineering Technologies

Opportunities
  • High Demand for Genome Engineering in Personalized Medicine
  • Growth Potential in Emerging market

Challenges
  • Complex Technology and Required High Skilled Researchers


Market Leaders and some development strategies
In Nov 2020, Eli Lilly and Company and Precision BioSciences, Inc. announced a research collaboration and exclusive license agreement to utilize Precision's proprietary ARCUS® genome editing platform for the research and development of potential in vivo therapies for genetic disorders, with an initial focus on Duchenne muscular dystrophy (DMD) and two other undisclosed gene targets.
In Feb 2018, Sangamo Therapeutics, Inc. announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) of the United Kingdom has granted the Clinical Trial Authorisation (CTA) for enrollment of subjects into the ongoing Phase 1/2 clinical trial evaluating SB-FIX, a zinc finger nuclease (ZFN)-mediated in vivo genome editing treatment for hemophilia B.


Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Genome Engineering Service Providers, Government Regulatory and Research Organizations and End-Use Industries

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Reagents & Consumables
  • Software & Systems
  • Services
By Application
  • Cell Line Engineering 
  • Animal Genetic Engineering 
  • Plant Genetic Engineering 
  • Others
By Technology
  • CRISPR
  • TALEN
  • ZFN
  • Antisense
  • Other Technologies

By End User
  • Biotechnology & Pharmaceutical Companies
  • Research Institutes
  • Contract Research Organizations

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Development of Novel Technologies in Genome Engineering
      • 3.2.2. Surging Prevalence of Genetic Disorders
    • 3.3. Market Challenges
      • 3.3.1. Complex Technology and Required High Skilled Researchers
    • 3.4. Market Trends
      • 3.4.1. Rising Governments Fundings for R&D in Genome Engineering
      • 3.4.2. Increasing Number of Strategic Initiative by Leading Players across the Industry
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Genome Engineering, by Type, Application, Technology, End User and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Genome Engineering (Value)
      • 5.2.1. Global Genome Engineering by: Type (Value)
        • 5.2.1.1. Reagents & Consumables
        • 5.2.1.2. Software & Systems
        • 5.2.1.3. Services
      • 5.2.2. Global Genome Engineering by: Application (Value)
        • 5.2.2.1. Cell Line Engineering 
        • 5.2.2.2. Animal Genetic Engineering 
        • 5.2.2.3. Plant Genetic Engineering 
        • 5.2.2.4. Others
      • 5.2.3. Global Genome Engineering by: Technology (Value)
        • 5.2.3.1. CRISPR
        • 5.2.3.2. TALEN
        • 5.2.3.3. ZFN
        • 5.2.3.4. Antisense
        • 5.2.3.5. Other Technologies
      • 5.2.4. Global Genome Engineering by: End User (Value)
        • 5.2.4.1. Biotechnology & Pharmaceutical Companies
        • 5.2.4.2. Research Institutes
        • 5.2.4.3. Contract Research Organizations
      • 5.2.5. Global Genome Engineering Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Genome Engineering: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Merck & Co (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Horizon Discovery Limited (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Genscript USA (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Sangamo Therapeutics (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Integrated DNA Technologies (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Lonza Group (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. New England Biolabs (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Origene Technologies (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Transposagen Biopharmaceuticals (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Genome Engineering Sale, by Type, Application, Technology, End User and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Genome Engineering (Value)
      • 7.2.1. Global Genome Engineering by: Type (Value)
        • 7.2.1.1. Reagents & Consumables
        • 7.2.1.2. Software & Systems
        • 7.2.1.3. Services
      • 7.2.2. Global Genome Engineering by: Application (Value)
        • 7.2.2.1. Cell Line Engineering 
        • 7.2.2.2. Animal Genetic Engineering 
        • 7.2.2.3. Plant Genetic Engineering 
        • 7.2.2.4. Others
      • 7.2.3. Global Genome Engineering by: Technology (Value)
        • 7.2.3.1. CRISPR
        • 7.2.3.2. TALEN
        • 7.2.3.3. ZFN
        • 7.2.3.4. Antisense
        • 7.2.3.5. Other Technologies
      • 7.2.4. Global Genome Engineering by: End User (Value)
        • 7.2.4.1. Biotechnology & Pharmaceutical Companies
        • 7.2.4.2. Research Institutes
        • 7.2.4.3. Contract Research Organizations
      • 7.2.5. Global Genome Engineering Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Genome Engineering: by Type(USD Million)
  • Table 2. Genome Engineering Reagents & Consumables , by Region USD Million (2015-2020)
  • Table 3. Genome Engineering Software & Systems , by Region USD Million (2015-2020)
  • Table 4. Genome Engineering Services , by Region USD Million (2015-2020)
  • Table 5. Genome Engineering: by Application(USD Million)
  • Table 6. Genome Engineering Cell Line Engineering  , by Region USD Million (2015-2020)
  • Table 7. Genome Engineering Animal Genetic Engineering  , by Region USD Million (2015-2020)
  • Table 8. Genome Engineering Plant Genetic Engineering  , by Region USD Million (2015-2020)
  • Table 9. Genome Engineering Others , by Region USD Million (2015-2020)
  • Table 10. Genome Engineering: by Technology(USD Million)
  • Table 11. Genome Engineering CRISPR , by Region USD Million (2015-2020)
  • Table 12. Genome Engineering TALEN , by Region USD Million (2015-2020)
  • Table 13. Genome Engineering ZFN , by Region USD Million (2015-2020)
  • Table 14. Genome Engineering Antisense , by Region USD Million (2015-2020)
  • Table 15. Genome Engineering Other Technologies , by Region USD Million (2015-2020)
  • Table 16. Genome Engineering: by End User(USD Million)
  • Table 17. Genome Engineering Biotechnology & Pharmaceutical Companies , by Region USD Million (2015-2020)
  • Table 18. Genome Engineering Research Institutes , by Region USD Million (2015-2020)
  • Table 19. Genome Engineering Contract Research Organizations , by Region USD Million (2015-2020)
  • Table 20. South America Genome Engineering, by Country USD Million (2015-2020)
  • Table 21. South America Genome Engineering, by Type USD Million (2015-2020)
  • Table 22. South America Genome Engineering, by Application USD Million (2015-2020)
  • Table 23. South America Genome Engineering, by Technology USD Million (2015-2020)
  • Table 24. South America Genome Engineering, by End User USD Million (2015-2020)
  • Table 25. Brazil Genome Engineering, by Type USD Million (2015-2020)
  • Table 26. Brazil Genome Engineering, by Application USD Million (2015-2020)
  • Table 27. Brazil Genome Engineering, by Technology USD Million (2015-2020)
  • Table 28. Brazil Genome Engineering, by End User USD Million (2015-2020)
  • Table 29. Argentina Genome Engineering, by Type USD Million (2015-2020)
  • Table 30. Argentina Genome Engineering, by Application USD Million (2015-2020)
  • Table 31. Argentina Genome Engineering, by Technology USD Million (2015-2020)
  • Table 32. Argentina Genome Engineering, by End User USD Million (2015-2020)
  • Table 33. Rest of South America Genome Engineering, by Type USD Million (2015-2020)
  • Table 34. Rest of South America Genome Engineering, by Application USD Million (2015-2020)
  • Table 35. Rest of South America Genome Engineering, by Technology USD Million (2015-2020)
  • Table 36. Rest of South America Genome Engineering, by End User USD Million (2015-2020)
  • Table 37. Asia Pacific Genome Engineering, by Country USD Million (2015-2020)
  • Table 38. Asia Pacific Genome Engineering, by Type USD Million (2015-2020)
  • Table 39. Asia Pacific Genome Engineering, by Application USD Million (2015-2020)
  • Table 40. Asia Pacific Genome Engineering, by Technology USD Million (2015-2020)
  • Table 41. Asia Pacific Genome Engineering, by End User USD Million (2015-2020)
  • Table 42. China Genome Engineering, by Type USD Million (2015-2020)
  • Table 43. China Genome Engineering, by Application USD Million (2015-2020)
  • Table 44. China Genome Engineering, by Technology USD Million (2015-2020)
  • Table 45. China Genome Engineering, by End User USD Million (2015-2020)
  • Table 46. Japan Genome Engineering, by Type USD Million (2015-2020)
  • Table 47. Japan Genome Engineering, by Application USD Million (2015-2020)
  • Table 48. Japan Genome Engineering, by Technology USD Million (2015-2020)
  • Table 49. Japan Genome Engineering, by End User USD Million (2015-2020)
  • Table 50. India Genome Engineering, by Type USD Million (2015-2020)
  • Table 51. India Genome Engineering, by Application USD Million (2015-2020)
  • Table 52. India Genome Engineering, by Technology USD Million (2015-2020)
  • Table 53. India Genome Engineering, by End User USD Million (2015-2020)
  • Table 54. South Korea Genome Engineering, by Type USD Million (2015-2020)
  • Table 55. South Korea Genome Engineering, by Application USD Million (2015-2020)
  • Table 56. South Korea Genome Engineering, by Technology USD Million (2015-2020)
  • Table 57. South Korea Genome Engineering, by End User USD Million (2015-2020)
  • Table 58. Taiwan Genome Engineering, by Type USD Million (2015-2020)
  • Table 59. Taiwan Genome Engineering, by Application USD Million (2015-2020)
  • Table 60. Taiwan Genome Engineering, by Technology USD Million (2015-2020)
  • Table 61. Taiwan Genome Engineering, by End User USD Million (2015-2020)
  • Table 62. Australia Genome Engineering, by Type USD Million (2015-2020)
  • Table 63. Australia Genome Engineering, by Application USD Million (2015-2020)
  • Table 64. Australia Genome Engineering, by Technology USD Million (2015-2020)
  • Table 65. Australia Genome Engineering, by End User USD Million (2015-2020)
  • Table 66. Rest of Asia-Pacific Genome Engineering, by Type USD Million (2015-2020)
  • Table 67. Rest of Asia-Pacific Genome Engineering, by Application USD Million (2015-2020)
  • Table 68. Rest of Asia-Pacific Genome Engineering, by Technology USD Million (2015-2020)
  • Table 69. Rest of Asia-Pacific Genome Engineering, by End User USD Million (2015-2020)
  • Table 70. Europe Genome Engineering, by Country USD Million (2015-2020)
  • Table 71. Europe Genome Engineering, by Type USD Million (2015-2020)
  • Table 72. Europe Genome Engineering, by Application USD Million (2015-2020)
  • Table 73. Europe Genome Engineering, by Technology USD Million (2015-2020)
  • Table 74. Europe Genome Engineering, by End User USD Million (2015-2020)
  • Table 75. Germany Genome Engineering, by Type USD Million (2015-2020)
  • Table 76. Germany Genome Engineering, by Application USD Million (2015-2020)
  • Table 77. Germany Genome Engineering, by Technology USD Million (2015-2020)
  • Table 78. Germany Genome Engineering, by End User USD Million (2015-2020)
  • Table 79. France Genome Engineering, by Type USD Million (2015-2020)
  • Table 80. France Genome Engineering, by Application USD Million (2015-2020)
  • Table 81. France Genome Engineering, by Technology USD Million (2015-2020)
  • Table 82. France Genome Engineering, by End User USD Million (2015-2020)
  • Table 83. Italy Genome Engineering, by Type USD Million (2015-2020)
  • Table 84. Italy Genome Engineering, by Application USD Million (2015-2020)
  • Table 85. Italy Genome Engineering, by Technology USD Million (2015-2020)
  • Table 86. Italy Genome Engineering, by End User USD Million (2015-2020)
  • Table 87. United Kingdom Genome Engineering, by Type USD Million (2015-2020)
  • Table 88. United Kingdom Genome Engineering, by Application USD Million (2015-2020)
  • Table 89. United Kingdom Genome Engineering, by Technology USD Million (2015-2020)
  • Table 90. United Kingdom Genome Engineering, by End User USD Million (2015-2020)
  • Table 91. Netherlands Genome Engineering, by Type USD Million (2015-2020)
  • Table 92. Netherlands Genome Engineering, by Application USD Million (2015-2020)
  • Table 93. Netherlands Genome Engineering, by Technology USD Million (2015-2020)
  • Table 94. Netherlands Genome Engineering, by End User USD Million (2015-2020)
  • Table 95. Rest of Europe Genome Engineering, by Type USD Million (2015-2020)
  • Table 96. Rest of Europe Genome Engineering, by Application USD Million (2015-2020)
  • Table 97. Rest of Europe Genome Engineering, by Technology USD Million (2015-2020)
  • Table 98. Rest of Europe Genome Engineering, by End User USD Million (2015-2020)
  • Table 99. MEA Genome Engineering, by Country USD Million (2015-2020)
  • Table 100. MEA Genome Engineering, by Type USD Million (2015-2020)
  • Table 101. MEA Genome Engineering, by Application USD Million (2015-2020)
  • Table 102. MEA Genome Engineering, by Technology USD Million (2015-2020)
  • Table 103. MEA Genome Engineering, by End User USD Million (2015-2020)
  • Table 104. Middle East Genome Engineering, by Type USD Million (2015-2020)
  • Table 105. Middle East Genome Engineering, by Application USD Million (2015-2020)
  • Table 106. Middle East Genome Engineering, by Technology USD Million (2015-2020)
  • Table 107. Middle East Genome Engineering, by End User USD Million (2015-2020)
  • Table 108. Africa Genome Engineering, by Type USD Million (2015-2020)
  • Table 109. Africa Genome Engineering, by Application USD Million (2015-2020)
  • Table 110. Africa Genome Engineering, by Technology USD Million (2015-2020)
  • Table 111. Africa Genome Engineering, by End User USD Million (2015-2020)
  • Table 112. North America Genome Engineering, by Country USD Million (2015-2020)
  • Table 113. North America Genome Engineering, by Type USD Million (2015-2020)
  • Table 114. North America Genome Engineering, by Application USD Million (2015-2020)
  • Table 115. North America Genome Engineering, by Technology USD Million (2015-2020)
  • Table 116. North America Genome Engineering, by End User USD Million (2015-2020)
  • Table 117. United States Genome Engineering, by Type USD Million (2015-2020)
  • Table 118. United States Genome Engineering, by Application USD Million (2015-2020)
  • Table 119. United States Genome Engineering, by Technology USD Million (2015-2020)
  • Table 120. United States Genome Engineering, by End User USD Million (2015-2020)
  • Table 121. Canada Genome Engineering, by Type USD Million (2015-2020)
  • Table 122. Canada Genome Engineering, by Application USD Million (2015-2020)
  • Table 123. Canada Genome Engineering, by Technology USD Million (2015-2020)
  • Table 124. Canada Genome Engineering, by End User USD Million (2015-2020)
  • Table 125. Mexico Genome Engineering, by Type USD Million (2015-2020)
  • Table 126. Mexico Genome Engineering, by Application USD Million (2015-2020)
  • Table 127. Mexico Genome Engineering, by Technology USD Million (2015-2020)
  • Table 128. Mexico Genome Engineering, by End User USD Million (2015-2020)
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Genome Engineering: by Type(USD Million)
  • Table 140. Genome Engineering Reagents & Consumables , by Region USD Million (2021-2026)
  • Table 141. Genome Engineering Software & Systems , by Region USD Million (2021-2026)
  • Table 142. Genome Engineering Services , by Region USD Million (2021-2026)
  • Table 143. Genome Engineering: by Application(USD Million)
  • Table 144. Genome Engineering Cell Line Engineering  , by Region USD Million (2021-2026)
  • Table 145. Genome Engineering Animal Genetic Engineering  , by Region USD Million (2021-2026)
  • Table 146. Genome Engineering Plant Genetic Engineering  , by Region USD Million (2021-2026)
  • Table 147. Genome Engineering Others , by Region USD Million (2021-2026)
  • Table 148. Genome Engineering: by Technology(USD Million)
  • Table 149. Genome Engineering CRISPR , by Region USD Million (2021-2026)
  • Table 150. Genome Engineering TALEN , by Region USD Million (2021-2026)
  • Table 151. Genome Engineering ZFN , by Region USD Million (2021-2026)
  • Table 152. Genome Engineering Antisense , by Region USD Million (2021-2026)
  • Table 153. Genome Engineering Other Technologies , by Region USD Million (2021-2026)
  • Table 154. Genome Engineering: by End User(USD Million)
  • Table 155. Genome Engineering Biotechnology & Pharmaceutical Companies , by Region USD Million (2021-2026)
  • Table 156. Genome Engineering Research Institutes , by Region USD Million (2021-2026)
  • Table 157. Genome Engineering Contract Research Organizations , by Region USD Million (2021-2026)
  • Table 158. South America Genome Engineering, by Country USD Million (2021-2026)
  • Table 159. South America Genome Engineering, by Type USD Million (2021-2026)
  • Table 160. South America Genome Engineering, by Application USD Million (2021-2026)
  • Table 161. South America Genome Engineering, by Technology USD Million (2021-2026)
  • Table 162. South America Genome Engineering, by End User USD Million (2021-2026)
  • Table 163. Brazil Genome Engineering, by Type USD Million (2021-2026)
  • Table 164. Brazil Genome Engineering, by Application USD Million (2021-2026)
  • Table 165. Brazil Genome Engineering, by Technology USD Million (2021-2026)
  • Table 166. Brazil Genome Engineering, by End User USD Million (2021-2026)
  • Table 167. Argentina Genome Engineering, by Type USD Million (2021-2026)
  • Table 168. Argentina Genome Engineering, by Application USD Million (2021-2026)
  • Table 169. Argentina Genome Engineering, by Technology USD Million (2021-2026)
  • Table 170. Argentina Genome Engineering, by End User USD Million (2021-2026)
  • Table 171. Rest of South America Genome Engineering, by Type USD Million (2021-2026)
  • Table 172. Rest of South America Genome Engineering, by Application USD Million (2021-2026)
  • Table 173. Rest of South America Genome Engineering, by Technology USD Million (2021-2026)
  • Table 174. Rest of South America Genome Engineering, by End User USD Million (2021-2026)
  • Table 175. Asia Pacific Genome Engineering, by Country USD Million (2021-2026)
  • Table 176. Asia Pacific Genome Engineering, by Type USD Million (2021-2026)
  • Table 177. Asia Pacific Genome Engineering, by Application USD Million (2021-2026)
  • Table 178. Asia Pacific Genome Engineering, by Technology USD Million (2021-2026)
  • Table 179. Asia Pacific Genome Engineering, by End User USD Million (2021-2026)
  • Table 180. China Genome Engineering, by Type USD Million (2021-2026)
  • Table 181. China Genome Engineering, by Application USD Million (2021-2026)
  • Table 182. China Genome Engineering, by Technology USD Million (2021-2026)
  • Table 183. China Genome Engineering, by End User USD Million (2021-2026)
  • Table 184. Japan Genome Engineering, by Type USD Million (2021-2026)
  • Table 185. Japan Genome Engineering, by Application USD Million (2021-2026)
  • Table 186. Japan Genome Engineering, by Technology USD Million (2021-2026)
  • Table 187. Japan Genome Engineering, by End User USD Million (2021-2026)
  • Table 188. India Genome Engineering, by Type USD Million (2021-2026)
  • Table 189. India Genome Engineering, by Application USD Million (2021-2026)
  • Table 190. India Genome Engineering, by Technology USD Million (2021-2026)
  • Table 191. India Genome Engineering, by End User USD Million (2021-2026)
  • Table 192. South Korea Genome Engineering, by Type USD Million (2021-2026)
  • Table 193. South Korea Genome Engineering, by Application USD Million (2021-2026)
  • Table 194. South Korea Genome Engineering, by Technology USD Million (2021-2026)
  • Table 195. South Korea Genome Engineering, by End User USD Million (2021-2026)
  • Table 196. Taiwan Genome Engineering, by Type USD Million (2021-2026)
  • Table 197. Taiwan Genome Engineering, by Application USD Million (2021-2026)
  • Table 198. Taiwan Genome Engineering, by Technology USD Million (2021-2026)
  • Table 199. Taiwan Genome Engineering, by End User USD Million (2021-2026)
  • Table 200. Australia Genome Engineering, by Type USD Million (2021-2026)
  • Table 201. Australia Genome Engineering, by Application USD Million (2021-2026)
  • Table 202. Australia Genome Engineering, by Technology USD Million (2021-2026)
  • Table 203. Australia Genome Engineering, by End User USD Million (2021-2026)
  • Table 204. Rest of Asia-Pacific Genome Engineering, by Type USD Million (2021-2026)
  • Table 205. Rest of Asia-Pacific Genome Engineering, by Application USD Million (2021-2026)
  • Table 206. Rest of Asia-Pacific Genome Engineering, by Technology USD Million (2021-2026)
  • Table 207. Rest of Asia-Pacific Genome Engineering, by End User USD Million (2021-2026)
  • Table 208. Europe Genome Engineering, by Country USD Million (2021-2026)
  • Table 209. Europe Genome Engineering, by Type USD Million (2021-2026)
  • Table 210. Europe Genome Engineering, by Application USD Million (2021-2026)
  • Table 211. Europe Genome Engineering, by Technology USD Million (2021-2026)
  • Table 212. Europe Genome Engineering, by End User USD Million (2021-2026)
  • Table 213. Germany Genome Engineering, by Type USD Million (2021-2026)
  • Table 214. Germany Genome Engineering, by Application USD Million (2021-2026)
  • Table 215. Germany Genome Engineering, by Technology USD Million (2021-2026)
  • Table 216. Germany Genome Engineering, by End User USD Million (2021-2026)
  • Table 217. France Genome Engineering, by Type USD Million (2021-2026)
  • Table 218. France Genome Engineering, by Application USD Million (2021-2026)
  • Table 219. France Genome Engineering, by Technology USD Million (2021-2026)
  • Table 220. France Genome Engineering, by End User USD Million (2021-2026)
  • Table 221. Italy Genome Engineering, by Type USD Million (2021-2026)
  • Table 222. Italy Genome Engineering, by Application USD Million (2021-2026)
  • Table 223. Italy Genome Engineering, by Technology USD Million (2021-2026)
  • Table 224. Italy Genome Engineering, by End User USD Million (2021-2026)
  • Table 225. United Kingdom Genome Engineering, by Type USD Million (2021-2026)
  • Table 226. United Kingdom Genome Engineering, by Application USD Million (2021-2026)
  • Table 227. United Kingdom Genome Engineering, by Technology USD Million (2021-2026)
  • Table 228. United Kingdom Genome Engineering, by End User USD Million (2021-2026)
  • Table 229. Netherlands Genome Engineering, by Type USD Million (2021-2026)
  • Table 230. Netherlands Genome Engineering, by Application USD Million (2021-2026)
  • Table 231. Netherlands Genome Engineering, by Technology USD Million (2021-2026)
  • Table 232. Netherlands Genome Engineering, by End User USD Million (2021-2026)
  • Table 233. Rest of Europe Genome Engineering, by Type USD Million (2021-2026)
  • Table 234. Rest of Europe Genome Engineering, by Application USD Million (2021-2026)
  • Table 235. Rest of Europe Genome Engineering, by Technology USD Million (2021-2026)
  • Table 236. Rest of Europe Genome Engineering, by End User USD Million (2021-2026)
  • Table 237. MEA Genome Engineering, by Country USD Million (2021-2026)
  • Table 238. MEA Genome Engineering, by Type USD Million (2021-2026)
  • Table 239. MEA Genome Engineering, by Application USD Million (2021-2026)
  • Table 240. MEA Genome Engineering, by Technology USD Million (2021-2026)
  • Table 241. MEA Genome Engineering, by End User USD Million (2021-2026)
  • Table 242. Middle East Genome Engineering, by Type USD Million (2021-2026)
  • Table 243. Middle East Genome Engineering, by Application USD Million (2021-2026)
  • Table 244. Middle East Genome Engineering, by Technology USD Million (2021-2026)
  • Table 245. Middle East Genome Engineering, by End User USD Million (2021-2026)
  • Table 246. Africa Genome Engineering, by Type USD Million (2021-2026)
  • Table 247. Africa Genome Engineering, by Application USD Million (2021-2026)
  • Table 248. Africa Genome Engineering, by Technology USD Million (2021-2026)
  • Table 249. Africa Genome Engineering, by End User USD Million (2021-2026)
  • Table 250. North America Genome Engineering, by Country USD Million (2021-2026)
  • Table 251. North America Genome Engineering, by Type USD Million (2021-2026)
  • Table 252. North America Genome Engineering, by Application USD Million (2021-2026)
  • Table 253. North America Genome Engineering, by Technology USD Million (2021-2026)
  • Table 254. North America Genome Engineering, by End User USD Million (2021-2026)
  • Table 255. United States Genome Engineering, by Type USD Million (2021-2026)
  • Table 256. United States Genome Engineering, by Application USD Million (2021-2026)
  • Table 257. United States Genome Engineering, by Technology USD Million (2021-2026)
  • Table 258. United States Genome Engineering, by End User USD Million (2021-2026)
  • Table 259. Canada Genome Engineering, by Type USD Million (2021-2026)
  • Table 260. Canada Genome Engineering, by Application USD Million (2021-2026)
  • Table 261. Canada Genome Engineering, by Technology USD Million (2021-2026)
  • Table 262. Canada Genome Engineering, by End User USD Million (2021-2026)
  • Table 263. Mexico Genome Engineering, by Type USD Million (2021-2026)
  • Table 264. Mexico Genome Engineering, by Application USD Million (2021-2026)
  • Table 265. Mexico Genome Engineering, by Technology USD Million (2021-2026)
  • Table 266. Mexico Genome Engineering, by End User USD Million (2021-2026)
  • Table 267. Research Programs/Design for This Report
  • Table 268. Key Data Information from Secondary Sources
  • Table 269. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Genome Engineering: by Type USD Million (2015-2020)
  • Figure 5. Global Genome Engineering: by Application USD Million (2015-2020)
  • Figure 6. Global Genome Engineering: by Technology USD Million (2015-2020)
  • Figure 7. Global Genome Engineering: by End User USD Million (2015-2020)
  • Figure 8. South America Genome Engineering Share (%), by Country
  • Figure 9. Asia Pacific Genome Engineering Share (%), by Country
  • Figure 10. Europe Genome Engineering Share (%), by Country
  • Figure 11. MEA Genome Engineering Share (%), by Country
  • Figure 12. North America Genome Engineering Share (%), by Country
  • Figure 13. Global Genome Engineering share by Players 2020 (%)
  • Figure 14. Global Genome Engineering share by Players (Top 3) 2020(%)
  • Figure 15. Global Genome Engineering share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 18. Thermo Fisher Scientific (United States) Revenue: by Geography 2020
  • Figure 19. Merck & Co (Germany) Revenue, Net Income and Gross profit
  • Figure 20. Merck & Co (Germany) Revenue: by Geography 2020
  • Figure 21. Horizon Discovery Limited (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 22. Horizon Discovery Limited (United Kingdom) Revenue: by Geography 2020
  • Figure 23. Genscript USA (United States) Revenue, Net Income and Gross profit
  • Figure 24. Genscript USA (United States) Revenue: by Geography 2020
  • Figure 25. Sangamo Therapeutics (United States) Revenue, Net Income and Gross profit
  • Figure 26. Sangamo Therapeutics (United States) Revenue: by Geography 2020
  • Figure 27. Integrated DNA Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 28. Integrated DNA Technologies (United States) Revenue: by Geography 2020
  • Figure 29. Lonza Group (Switzerland) Revenue, Net Income and Gross profit
  • Figure 30. Lonza Group (Switzerland) Revenue: by Geography 2020
  • Figure 31. New England Biolabs (United States) Revenue, Net Income and Gross profit
  • Figure 32. New England Biolabs (United States) Revenue: by Geography 2020
  • Figure 33. Origene Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 34. Origene Technologies (United States) Revenue: by Geography 2020
  • Figure 35. Transposagen Biopharmaceuticals (United States) Revenue, Net Income and Gross profit
  • Figure 36. Transposagen Biopharmaceuticals (United States) Revenue: by Geography 2020
  • Figure 37. Global Genome Engineering: by Type USD Million (2021-2026)
  • Figure 38. Global Genome Engineering: by Application USD Million (2021-2026)
  • Figure 39. Global Genome Engineering: by Technology USD Million (2021-2026)
  • Figure 40. Global Genome Engineering: by End User USD Million (2021-2026)
  • Figure 41. South America Genome Engineering Share (%), by Country
  • Figure 42. Asia Pacific Genome Engineering Share (%), by Country
  • Figure 43. Europe Genome Engineering Share (%), by Country
  • Figure 44. MEA Genome Engineering Share (%), by Country
  • Figure 45. North America Genome Engineering Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Thermo Fisher Scientific (United States)
  • Merck & Co (Germany)
  • Horizon Discovery Limited (United Kingdom)
  • Genscript USA (United States)
  • Sangamo Therapeutics (United States)
  • Integrated DNA Technologies (United States)
  • Lonza Group (Switzerland)
  • New England Biolabs (United States)
  • Origene Technologies (United States)
  • Transposagen Biopharmaceuticals (United States)
Additional players considered in the study are as follows:
Cellecta (United States) , Genecopoeia (United States) , Calyxt (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation